Meng, FanbenMeyer, Carolyn MJoung, DaehaVallera, Daniel AMcAlpine, Michael CPanoskaltsis-Mortari, Angela2020-05-292020-05-292020-05-29https://hdl.handle.net/11299/213837A full description of the data set is included in the file "Readme_Meng_Tumor_Model.txt".The data set includes the experimental data and the corresponding code files for " 3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments", Fanben Meng, Carolyn M Meyer, Daeha Joung, Daniel A Vallera, Michael C McAlpine, Angela Panoskaltsis‐Mortari, Adv. Mater. 2019, 31 (10), 1806899. The development of 3D in vitro models capable of recapitulating native tumor microenvironments could improve the translatability of potential anticancer drugs and treatments. Here, 3D bioprinting techniques are used to build tumor constructs via precise placement of living cells, functional biomaterials, and programmable release capsules. This enables the spatiotemporal control of signaling molecular gradients, thereby dynamically modulating cellular behaviors at a local level. Vascularized tumor models are created to mimic key steps of cancer dissemination (invasion, intravasation, and angiogenesis), based on guided migration of tumor cells and endothelial cells in the context of stromal cells and growth factors. The utility of the metastatic models for drug screening is demonstrated by evaluating the anticancer efficacy of immunotoxins. These 3D vascularized tumor tissues provide a proof-of-concept platform to i) fundamentally explore the molecular mechanisms of tumor progression and metastasis, and ii) preclinically identify therapeutic agents and screen anticancer drugs.Attribution-NonCommercial-NoDerivs 3.0 United Stateshttp://creativecommons.org/licenses/by-nc-nd/3.0/us/3D printingBioprintingTumor metastatic modelGuided cell migrationDrug ScreeningDatasethttps://doi.org/10.13020/xxnh-v194